Imunon (IMNN) Operating Expenses (2010 - 2026)
Imunon's (IMNN) quarterly Operating Expenses came in at $4.3 million in Q1 2026, up 3.89% YoY from $4.1 million in Q1 2025, and up 1.05% on a QoQ basis from $4.3 million in Q4 2025.
Imunon (IMNN) Operating Expenses (2010 - 2026) Analysis & Trends
Imunon (IMNN) has 17 years of Operating Expenses data on file, last reported at $4.3 million in Q1 2026.
- Quarterly Operating Expenses rose 3.89% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.8 million (down 18.91% YoY) and the FY2025 annual result came in at $14.7 million, down 23.42% from the prior year.
- Operating Expenses advanced to $4.3 million in Q1 2026, from $4.3 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $7.1 million in Q4 2022 to a low of $2.8 million in Q2 2025.
- A 5-year average of $5.0 million and a median of $5.0 million in 2024 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2024 — Operating Expenses climbed 27.08% — and 2025, when it plunged 44.79%.
- Tracing IMNN's Operating Expenses over 5 years: stood at $7.1 million in 2022, then decreased by 15.37% to $6.0 million in 2023, then tumbled by 30.52% to $4.1 million in 2024, then gained by 2.79% to $4.3 million in 2025, then grew by 1.05% to $4.3 million in 2026.
- The last three Operating Expenses figures came in at $4.3 million (Q1 2026), $4.3 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Imunon | 8.16 Mn | 8.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.31 Mn |
| Dec 31, 2025 | 4.26 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Jun 30, 2025 | 2.77 Mn |
| Mar 31, 2025 | 4.15 Mn |
| Dec 31, 2024 | 4.15 Mn |
| Sep 30, 2024 | 4.96 Mn |
| Jun 30, 2024 | 5.01 Mn |
| Mar 31, 2024 | 5.01 Mn |
| Dec 31, 2023 | 5.97 Mn |
| Sep 30, 2023 | 3.90 Mn |
| Jun 30, 2023 | 5.47 Mn |
| Mar 31, 2023 | 5.68 Mn |
| Dec 31, 2022 | 7.05 Mn |
| Sep 30, 2022 | 6.30 Mn |
| Jun 30, 2022 | 6.10 Mn |
| Mar 31, 2022 | 5.97 Mn |
| Dec 31, 2021 | 5.62 Mn |
| Sep 30, 2021 | 5.19 Mn |
| Jun 30, 2021 | 5.20 Mn |